Net Profit Margin
since 2005
Calculation
Thermo Fisher Scientific Inc., net profit margin, long-term trends, calculation
| Net profit margin | = | 100 | × | Net income attributable to Thermo Fisher Scientific Inc.1 | ÷ | Revenues1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 14.77% | = | 100 | × | 6,335) | ÷ | 42,879) |
| Dec 31, 2023 | 13.99% | = | 100 | × | 5,995) | ÷ | 42,857) |
| Dec 31, 2022 | 15.47% | = | 100 | × | 6,950) | ÷ | 44,915) |
| Dec 31, 2021 | 19.70% | = | 100 | × | 7,725) | ÷ | 39,211) |
| Dec 31, 2020 | 19.79% | = | 100 | × | 6,375) | ÷ | 32,218) |
| Dec 31, 2019 | 14.47% | = | 100 | × | 3,696) | ÷ | 25,542) |
| Dec 31, 2018 | 12.06% | = | 100 | × | 2,938) | ÷ | 24,358) |
| Dec 31, 2017 | 10.64% | = | 100 | × | 2,225) | ÷ | 20,918) |
| Dec 31, 2016 | 11.06% | = | 100 | × | 2,022) | ÷ | 18,274) |
| Dec 31, 2015 | 11.64% | = | 100 | × | 1,975) | ÷ | 16,965) |
| Dec 31, 2014 | 11.22% | = | 100 | × | 1,894) | ÷ | 16,890) |
| Dec 31, 2013 | 9.73% | = | 100 | × | 1,273) | ÷ | 13,090) |
| Dec 31, 2012 | 9.42% | = | 100 | × | 1,178) | ÷ | 12,510) |
| Dec 31, 2011 | 11.34% | = | 100 | × | 1,330) | ÷ | 11,726) |
| Dec 31, 2010 | 9.60% | = | 100 | × | 1,036) | ÷ | 10,789) |
| Dec 31, 2009 | 8.41% | = | 100 | × | 850) | ÷ | 10,110) |
| Dec 31, 2008 | 9.47% | = | 100 | × | 994) | ÷ | 10,498) |
| Dec 31, 2007 | 7.81% | = | 100 | × | 761) | ÷ | 9,746) |
| Dec 31, 2006 | 4.46% | = | 100 | × | 169) | ÷ | 3,792) |
| Dec 31, 2005 | 8.48% | = | 100 | × | 223) | ÷ | 2,633) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
- Net Income Attributable to Thermo Fisher Scientific Inc.
- The net income shows a general upward trend from 2005 through 2024, with values increasing from $223 million to $6,335 million. There are some fluctuations, such as a decline in 2006 and 2009, followed by steady growth. Notably, from 2014 to 2021, net income experienced significant growth, peaking at $7,725 million in 2021 before declining in 2022 and 2023, then slightly recovering in 2024.
- Revenues
- Revenues display a consistent growth pattern over the period, rising from $2,633 million in 2005 to $42,879 million in 2024. The growth is steady with minor fluctuations, including a small dip in 2023 relative to the previous year. The largest increases occur between 2014 and 2022, where revenue expands rapidly, implying robust business expansion or acquisitions during those years.
- Net Profit Margin
- The net profit margin exhibits variability, starting at 8.48% in 2005. It decreases in 2006 but generally trends upward with some fluctuations. The margin peaks at 19.79% in 2020, indicating improved profitability relative to revenue during this period. After this peak, there is a decline in 2022 and 2023, with margins falling to approximately 14%, followed by a slight increase in 2024. Overall, the margin improvement over the two decades suggests enhanced operational efficiency or higher margin products/services.
Comparison to Competitors
Thermo Fisher Scientific Inc., net profit margin, long-term trends, comparison to competitors
| Thermo Fisher Scientific Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 14.77% | 7.59% | 12.77% | -18.53% | 16.33% | 23.51% | 1.68% | 15.84% | 26.68% | 12.62% | 31.07% | -4.86% |
| Dec 31, 2023 | 13.99% | 8.95% | 24.96% | 17.83% | 19.94% | 15.36% | 21.03% | 41.28% | 0.61% | 3.56% | 30.14% | 36.68% |
| Dec 31, 2022 | 15.47% | 20.39% | 26.42% | 13.71% | 22.91% | 21.88% | 17.02% | 18.90% | 24.49% | 31.01% | 35.64% | 37.20% |
| Dec 31, 2021 | 19.70% | 20.54% | 24.25% | 15.08% | 21.84% | 19.71% | 23.05% | 22.26% | 26.79% | 26.76% | 50.25% | 30.92% |
| Dec 31, 2020 | 19.79% | 10.08% | 29.97% | -21.20% | 16.36% | 25.24% | 0.51% | 17.82% | 14.72% | 22.53% | 41.35% | 43.70% |
| Dec 31, 2019 | 14.47% | 23.69% | 35.32% | 13.15% | 16.80% | 37.27% | 24.35% | 18.42% | 21.01% | 31.45% | 26.91% | 28.27% |
| Dec 31, 2018 | 12.06% | 17.36% | 37.25% | 21.81% | 13.33% | 13.16% | 25.16% | 18.75% | 14.71% | 20.79% | 36.42% | 68.80% |
| Dec 31, 2017 | 10.64% | 18.82% | 9.08% | 4.85% | 13.60% | -0.89% | 18.03% | 1.70% | 5.97% | 40.55% | 20.41% | 10.59% |
| Dec 31, 2016 | 11.06% | 23.22% | 35.27% | 22.94% | 15.13% | 12.90% | 45.07% | 23.01% | 9.85% | 13.66% | 18.42% | -6.58% |
| Dec 31, 2015 | 11.64% | 22.50% | 33.13% | 9.45% | 16.33% | 12.07% | 56.32% | 21.99% | 11.25% | 14.25% | 15.50% | -53.89% |
| Dec 31, 2014 | 11.22% | 8.89% | 26.69% | 12.62% | 13.05% | 12.19% | 49.44% | 21.96% | 28.22% | 18.42% | 12.34% | -127.25% |
| Dec 31, 2013 | 9.73% | 21.97% | 27.93% | 15.64% | 14.10% | 20.27% | 28.46% | 19.40% | 10.00% | 42.65% | 20.16% | -36.72% |
| Dec 31, 2012 | 9.42% | 28.70% | 26.11% | 11.12% | 13.10% | 18.09% | 27.57% | 16.14% | 13.05% | 24.70% | 54.43% | -7.01% |
| Dec 31, 2011 | 11.34% | — | 24.08% | 17.46% | 13.50% | 17.90% | 34.60% | 14.87% | 13.05% | 14.84% | -49.74% | 2.10% |
| Dec 31, 2010 | 9.60% | — | 31.56% | 15.92% | 13.58% | 21.97% | 39.26% | 21.65% | 1.87% | 12.18% | -22.76% | -526.35% |
| Dec 31, 2009 | 8.41% | — | 32.09% | 56.42% | 10.30% | 19.82% | 40.74% | 19.82% | 47.04% | 17.27% | -17.88% | -630.27% |
| Dec 31, 2008 | 9.47% | — | 28.57% | 25.47% | 10.38% | -10.17% | 39.55% | 20.31% | 32.74% | 16.78% | -34.69% | -262.02% |
| Dec 31, 2007 | 7.81% | — | 22.12% | 11.19% | 12.42% | 15.85% | 43.27% | 17.31% | 13.54% | 16.82% | -84.46% | -196.61% |
| Dec 31, 2006 | 4.46% | — | 21.29% | 8.85% | 11.69% | 16.97% | -45.98% | 20.73% | 19.59% | 39.98% | -161.30% | -95.63% |
| Dec 31, 2005 | 8.48% | — | 30.56% | 15.62% | 11.24% | 13.52% | 44.99% | 20.61% | 21.04% | 15.76% | -144.19% | -126.43% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Thermo Fisher Scientific Inc., net profit margin, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Thermo Fisher Scientific Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 31, 2024 | 14.77% | 12.30% |
| Dec 31, 2023 | 13.99% | 17.95% |
| Dec 31, 2022 | 15.47% | 22.55% |
| Dec 31, 2021 | 19.70% | 23.38% |
| Dec 31, 2020 | 19.79% | 14.07% |
| Dec 31, 2019 | 14.47% | 23.22% |
| Dec 31, 2018 | 12.06% | 19.82% |
| Dec 31, 2017 | 10.64% | 13.06% |
| Dec 31, 2016 | 11.06% | 20.78% |
| Dec 31, 2015 | 11.64% | 21.17% |
| Dec 31, 2014 | 11.22% | 21.24% |
| Dec 31, 2013 | 9.73% | 21.99% |
| Dec 31, 2012 | 9.42% | 18.53% |
| Dec 31, 2011 | 11.34% | 15.70% |
| Dec 31, 2010 | 9.60% | 15.16% |
| Dec 31, 2009 | 8.41% | 25.73% |
| Dec 31, 2008 | 9.47% | 18.17% |
| Dec 31, 2007 | 7.81% | 15.90% |
| Dec 31, 2006 | 4.46% | 22.24% |
| Dec 31, 2005 | 8.48% | 18.33% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Thermo Fisher Scientific Inc., net profit margin, long-term trends, comparison to industry (health care)
| Thermo Fisher Scientific Inc. | Health Care | |
|---|---|---|
| Dec 31, 2024 | 14.77% | 7.02% |
| Dec 31, 2023 | 13.99% | 9.24% |
| Dec 31, 2022 | 15.47% | 11.62% |
| Dec 31, 2021 | 19.70% | 12.42% |
| Dec 31, 2020 | 19.79% | 8.45% |
| Dec 31, 2019 | 14.47% | 11.58% |
| Dec 31, 2018 | 12.06% | 9.92% |
| Dec 31, 2017 | 10.64% | 8.05% |
| Dec 31, 2016 | 11.06% | 10.68% |
| Dec 31, 2015 | 11.64% | 11.77% |
| Dec 31, 2014 | 11.22% | 12.15% |
| Dec 31, 2013 | 9.73% | 12.81% |
| Dec 31, 2012 | 9.42% | 11.86% |
| Dec 31, 2011 | 11.34% | 10.50% |
| Dec 31, 2010 | 9.60% | 10.48% |
| Dec 31, 2009 | 8.41% | 15.08% |
| Dec 31, 2008 | 9.47% | 11.35% |
| Dec 31, 2007 | 7.81% | 11.02% |
| Dec 31, 2006 | 4.46% | 13.95% |
| Dec 31, 2005 | 8.48% | 13.38% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).